Tag Archives: Ironwood

Corporate Spinoff Monthly Roundup – April 2019

By |
0 Comment

Another month is almost in the books so lets recap the recent spinoff activity and also take a look at what spinoffs the next month will bring: Spinoffs Completed Prior Month Some big spinoffs in April. April 1st – after several years of merger integration work, DowDupont (DWDP) began breaking itself up last month with  the spin off… Read More »

Ironwood Tries To Hit for The Cyclerion With Spinoff On Deck As Spring Training Winds Down

By |
2 Comments

Born as Microbia over twenty years ago, Ironwood Pharmaceuticals(IRWD) trades just 21% above its 2010 IPO price. It has managed to get to market with LINZESS, a treatment for IBS. Partnered with Allergan(AGN), LINZESS did $761.2 million in 2018 US sales. Now, Ironwood will be spinning off much of its R&D business as Cyclerion. Current Ironwood CEO and… Read More »